Global Transcatheter Aortic Valve Replacement Market 2016-2020

Global Transcatheter Aortic Valve Replacement Market 2016-2020

Category : Medical Devices
Published On : January  2016
Pages : 49

------------ Or -------------
About Transcatheter Aortic Valve Replacement

Transcatheter heart valve replacement systems are cardiovascular devices that repair the aortic valve without removing the old and damaged valves. It is used to treat aortic valve disorders such as regurgitation, aortic stenosis, and degeneration. TAVI is performed in two ways, transfemoral approach (through the femoral artery) and transapical approach (through a small chest incision).

Technavios analysts forecast the global TAVR market to grow at a CAGR of 16.9% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global TAVR market for the period 2015-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valve implants.

The market is divided into the following segments based on geography: 

Technavios report, Global Transcatheter Aortic Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
Edwards Lifesciences
Boston Scientific
St. Jude Medical 

Other prominent vendors 
Direct Flow Medical
JenaValve Technology
Meril Life Sciences

Market driver 
Rise in prevalence of aortic stenosis with increase in aging population
For a full, detailed list, view our report 

Market challenge 
Risk of potential complications
For a full, detailed list, view our report 

Market trend 
Focus on clinical trials
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

PART 01: Executive summary

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Clinical trial studies on TAVR

PART 07: Cost analysis
Cost analysis of aortic valve replacement procedures

PART 08: Market segmentation by product
Transfemoral implantation
Transapical implantation

PART 09: Geographical segmentation
Global TAVR market by geography 2015-2020
TAVR market in EMEA
TAVR market in Americas
TAVR market in APAC

PART 10: TAVR market in US
TAVR market in the US

PART 11: Market drivers
Rise in prevalence of aortic stenosis with increase in aging population
Launch of novel transcatheter valve implants in US and Japan
Increase in adoption of MI procedures

PART 12: Impact of drivers

PART 13: Market challenges
Risk of potential complications
Threat from surgical valve implant procedures
Stringent regulations
Lack of of skilled practitioners

PART 14: Impact of drivers and challenges

PART 15: Market trends
Focus on clinical trials
Development of TAVR technology and self-expandable stent frame
Devices for a younger and lower-risk patient population

PART 16: Vendor landscape
Competitive scenario
Key vendor analysis
Other prominent vendors

PART 17: Appendix
List of abbreviation

PART 18: Explore Technavio

List Of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global TAVR market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Snapshot of TAVR device studies in clinical trials
Exhibit 05: Comparison of the cost involved in valve replacement procedures (high risk group)
Exhibit 06: Segmentation of TAVR market by product
Exhibit 07: Comparison of transfemoral and transapical implantation approaches
Exhibit 08: Global TAVR market by geography 2015
Exhibit 09: Global TAVR market by geography 2020
Exhibit 10: Segmentation global TAVR market by geography 2015-2020
Exhibit 11: TAVR market in EMEA 2015-2020 ($ millions)
Exhibit 12: TAVR market in Americas 2015-2020 ($ millions)
Exhibit 13: TAVR market in APAC 2015-2020 ($ millions)
Exhibit 14: TAVR market in US 2015-2020 ($ millions)
Exhibit 15: Pipeline snapshot of TAVR in US
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: TAVR systems with FDA approval 2011-2015
Exhibit 19: TAVR systems with CE mark approval 2007-2015
Exhibit 20: Product portfolio matrix for key vendors 2015
Exhibit 21: Market share analysis 2015
Exhibit 22: Edwards Lifesciences: Key takeaways
Exhibit 23: Medtronic: Key takeaways
Exhibit 24: Boston Scientific: Key takeaways
Exhibit 25: St. Jude Medical: Key takeaways

Enquiry Before Buy